Clinical Leader

How To Determine Country Feasibility For Cell And Gene Therapy Clinical Trials

Author Image

by Jessica Cordes  - April 17, 2024

Share 0
Tweet 0
Pin 0
Share 0
Tweet 0
Pin 0

Guest Column | April 17, 2024

How To Determine Country Feasibility For Cell And Gene Therapy Clinical Trials

By Jessica Cordes, senior consultant, Clinical Excellence GmbH

Choosing the right geography for your clinical trial can affect your overall trial success and eventual product launch speed and potential. 

Please read the full Clinical Leader Article.

About the Author

Jessica Cordes

Follow me

Share 0

Jessica Cordes is Managing Director of Clinical Excellence GmbH. She has 15+ years in clinical operations and previously served as Head of Clinical Operations at Immatics Biotechnologies and Medigene Immunotherapies, leading first-in-human cell & gene therapy trials.

bonus

Get a Checklist with Critical Processes and Records

 Send me the Checklist
Site Feasibility Tips For Cell And Gene Therapy Clinical Trials
Umbrella? Basket? Discover 4 Types of Adaptive Clinical Trials And Their Benefits
 Previous Post
Next Post

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

You may be interested in

Clinical Leader

Aligning AI Use Clinical Trials With FDA And EMA Expectations

Clinical Leader

Why The EU Biotech Act Matters To The U.S.: A Clinical Perspective